One patient was reported carrying 12p gain on both GCNIS and in primary TGCT, while KRAS mutation was detected only in the TGCT, suggesting the two alterations are separate processes acquired during tumor evolution [33]. The gene discussed is KRAS; the disease is neoplasm.